These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21827946)

  • 1. The structural basis for the function of two anti-VEGF receptor 2 antibodies.
    Franklin MC; Navarro EC; Wang Y; Patel S; Singh P; Zhang Y; Persaud K; Bari A; Griffith H; Shen L; Balderes P; Kussie P
    Structure; 2011 Aug; 19(8):1097-107. PubMed ID: 21827946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.
    Muller YA; Chen Y; Christinger HW; Li B; Cunningham BC; Lowman HB; de Vos AM
    Structure; 1998 Sep; 6(9):1153-67. PubMed ID: 9753694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiangiogenic activity of a soluble fragment of the VEGFR extracellular domain.
    Li H; Cao W; Chen Z; Acheampong DO; Jin H; Li D; Zhang J; Wang M
    Biomed Pharmacother; 2013 Sep; 67(7):599-606. PubMed ID: 23906761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a highly-potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding site.
    Ghavamipour F; Shahangian SS; Sajedi RH; Arab SS; Mansouri K; Aghamaali MR
    FEBS J; 2014 Oct; 281(19):4479-94. PubMed ID: 25132001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding.
    Iyer S; Scotney PD; Nash AD; Ravi Acharya K
    J Mol Biol; 2006 May; 359(1):76-85. PubMed ID: 16616187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of vascular endothelial growth factor-B in complex with a neutralising antibody Fab fragment.
    Leonard P; Scotney PD; Jabeen T; Iyer S; Fabri LJ; Nash AD; Acharya KR
    J Mol Biol; 2008 Dec; 384(5):1203-17. PubMed ID: 18930733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2.
    Miao HQ; Hu K; Jimenez X; Navarro E; Zhang H; Lu D; Ludwig DL; Balderes P; Zhu Z
    Biochem Biophys Res Commun; 2006 Jun; 345(1):438-45. PubMed ID: 16682007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of IL-17A in complex with a potent, fully human neutralizing antibody.
    Gerhardt S; Abbott WM; Hargreaves D; Pauptit RA; Davies RA; Needham MR; Langham C; Barker W; Aziz A; Snow MJ; Dawson S; Welsh F; Wilkinson T; Vaugan T; Beste G; Bishop S; Popovic B; Rees G; Sleeman M; Tuske SJ; Coales SJ; Hamuro Y; Russell C
    J Mol Biol; 2009 Dec; 394(5):905-21. PubMed ID: 19835883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy.
    Ran S; Huang X; Downes A; Thorpe PE
    Neoplasia; 2003; 5(4):297-307. PubMed ID: 14511401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periplasmic expression optimization of VEGFR2 D3 adopting response surface methodology: antiangiogenic activity study.
    Cao W; Li H; Zhang J; Li D; Acheampong DO; Chen Z; Wang M
    Protein Expr Purif; 2013 Aug; 90(2):55-66. PubMed ID: 23680780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity.
    Zhu Z; Hattori K; Zhang H; Jimenez X; Ludwig DL; Dias S; Kussie P; Koo H; Kim HJ; Lu D; Liu M; Tejada R; Friedrich M; Bohlen P; Witte L; Rafii S
    Leukemia; 2003 Mar; 17(3):604-11. PubMed ID: 12646950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust Antibody-Antigen Complexes Prediction Generated by Combining Sequence Analyses, Mutagenesis, In Vitro Evolution, X-ray Crystallography and In Silico Docking.
    Loyau J; Didelot G; Malinge P; Ravn U; Magistrelli G; Depoisier JF; Pontini G; Poitevin Y; Kosco-Vilbois M; Fischer N; Thore S; Rousseau F
    J Mol Biol; 2015 Aug; 427(16):2647-62. PubMed ID: 26013163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
    J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The VD1 neutralizing antibody to vascular endothelial growth factor-D: binding epitope and relationship to receptor binding.
    Davydova N; Roufail S; Streltsov VA; Stacker SA; Achen MG
    J Mol Biol; 2011 Apr; 407(4):581-93. PubMed ID: 21315726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes.
    Arevalo JH; Hassig CA; Stura EA; Sims MJ; Taussig MJ; Wilson IA
    J Mol Biol; 1994 Sep; 241(5):663-90. PubMed ID: 8071992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conformation-based phage-display panning to screen neutralizing anti-VEGF VHHs with VEGFR2 mimicry behavior.
    Shahangian SS; H Sajedi R; Hasannia S; Jalili S; Mohammadi M; Taghdir M; Shali A; Mansouri K; Sariri R
    Int J Biol Macromol; 2015; 77():222-34. PubMed ID: 25748850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
    Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
    J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2.
    Erdag B; Balcioglu BK; Bahadir AO; Serhatli M; Kacar O; Bahar A; Seker UO; Akgun E; Ozkan A; Kilic T; Tamerler C; Baysal K
    Biotechnol Appl Biochem; 2011; 58(6):412-22. PubMed ID: 22172104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.